Quantcast Table XII. Early Bioassay Measurement Results Corresponding to the Therapeutic Intervention Action Levels Used at the Hanford Site (Carbaugh et al. 1995) (Part 1)

 

Click here to make tpub.com your Home Page

Page Title: Table XII. Early Bioassay Measurement Results Corresponding to the Therapeutic Intervention Action Levels Used at the Hanford...
Back | Up | Next

Click here for thousands of PDF manuals

Google


Web
www.tpub.com

Home

   
Information Categories
.... Administration
Advancement
Aerographer
Automotive
Aviation
Construction
Diving
Draftsman
Engineering
Electronics
Food and Cooking
Logistics
Math
Medical
Music
Nuclear Fundamentals
Photography
Religion
   
   

 

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Back
Treatment Criteria-when to Treat
Up
Internal Dosimetry - index
Next
Table XIII. Early Bioassay Measurement Results Corresponding to the Therapeutic Intervention Action Levels Used at the Hanford Site (Carbaugh et al. 1995) (Part 2)


DOE-STD-1121-98
Table XII. Early Bioassay Measurement Results Corresponding to the Therapeutic Intervention
Action Levels Used at the Hanford Site (Carbaugh et al. 1995) (Part 1)
Measurement
Result
Action
Possible
Isotope and
Dose (HE,50)
Treatment
Tritium
106 dpm/mL
2 rems
Single-void urine
Consider
Fluids, diuretics
3-4 h after
therapy
exposure
107 dpm/mL
Strongly
20 rems
Same
Fluids,
recommend
diuretics
treatment
Mixed Fission Products
2 rems
Whole body
>2500 nCi uptake, or
Consider
Prussian blue
(assumes 2:1
count, or
>40,000 nCi if no Sr
therapy
Ca,(Sr),
Sr/Cs ratio)
urine/fecal for
present
ammonium
severe intakes
phosphate, others
20 rems
Same
>25,000 nCi uptake,
Treatment
Same
(assumes 2:1
or
strongly
Sr/Cs ratio
>400,000 nCi if no Sr
recommended
present
90
Sr
2 rems
Second-void spot
>200,000 dpm in spot
Consider
Alginate, Ca
urine or in vivo
urine,
therapy
gluconate, Sr
detection
or
lactate, others
>MDA in vivo
Treatment
Same
20 rems
Same
>2,000,000 dpm in
strongly
spot urine, or
>50 :Ci in vivo
recommended
arguable. Knowledge of facility operations, material forms, and past experience will likely play a key
role in development of such criteria.
10.4 TREATMENT PROTOCOLS - HOW TO TREAT
Treatment can be considered to include both skin decontamination to prevent intake and intervention
actions taken to reduce internal dose once an intake has occurred. Skin decontamination protocols
beyond simple washing should be reviewed by appropriate medical authorities to ensure that
107


Privacy Statement - Press Release - Copyright Information. - Contact Us

Integrated Publishing, Inc.